Arcadia Biosciences discloses CFO Thomas Schaefer compensation: $260K base, 40% bonus target, 50,000 stock options

Arcadia Biosciences, Inc.

Base salary $260,000 per annum; target bonus 40% of base salary as per employment letter effective Jan 3, 2023.
Granted stock options to purchase 50,000 shares vesting over 4 years with 1-year cliff under 2015 Omnibus Plan.
Severance: 6-month base salary non-CIC; 12-month salary + 100% equity vesting if terminated within 12 months post-change-in-control.
Employment is at-will; CIC agreement expires on third anniversary of effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.